$3.03
-0.02-0.66%
Last update: Nov 2, 9:04 AM
Neuphoria Therapeutics Inc (NEUP) Stock Price, Quote, News & History
NEUPNASDAQ
Stocks in focus: Abivax, Marygold and Neuphoria report losses; Accenture partners with Anthropic, while Lobo Technologies posts H1 growth.
You can purchase shares of Neuphoria Therapeutics (NASDAQ:NEUP) through any online brokerage.
Other companies in Neuphoria Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Neuphoria Therapeutics has a consensus price target of $35.00.
The stock price for Neuphoria Therapeutics (NASDAQ: NEUP) is $3.03 last updated November 2, 2026 at 9:04 AM EST.
There are no upcoming dividends for Neuphoria Therapeutics.
Neuphoria Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Neuphoria Therapeutics.
Neuphoria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company focused on therapies for serious central nervous system disorders. Its lead product candidate, BNC210, is an oral, proprietary, selective negative allosteric modulator of the alpha7...
